HealthEU-Startupsabout 3 hours ago
SRTD Biotech Secures 31.5 Million Euro Funding
3 min read
Jülich-based SRTD Biotech completes an oversubscribed €31.5 million seed financing round led by Mérieux Equity Partners. The funding supports development of precision mRNA therapies using proprietary seRNA technology and AI-driven design. Matthias Alder joins as CEO, while Dr. Heinz Koeppl becomes CTO to lead the scientific strategy.
Level
Hype check
Tap to vote and see what everyone thinks.